# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-21-014205
Filing Date
2021-03-18
Accepted
2021-03-18 17:25:28
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | acet-defa14a_20210427.htm | DEFA14A | 32433
2 | GRAPHIC | gpk4ikhwawvu000002.jpg | GRAPHIC | 319943
3 | GRAPHIC | gpk4ikhwawvu000001.jpg | GRAPHIC | 397400
| Complete submission text file | 0001564590-21-014205.txt |  | 1021185

Mailing Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38359 | Film No.: 21755506
SIC: 2834 Pharmaceutical Preparations